Immune thrombocytopenia (ITP) was reported as a rare complication of COVID‐19 vaccines. We conducted a retrospective single‐center analysis of all ITP cases detected in 2021 and compared the quantity with… Click to show full abstract
Immune thrombocytopenia (ITP) was reported as a rare complication of COVID‐19 vaccines. We conducted a retrospective single‐center analysis of all ITP cases detected in 2021 and compared the quantity with the pre‐vaccination years, from 2018 to 2020. In 2021, a two‐fold increase in ITP cases was identified compared to previous years; 11 of 40 cases (27.5%) were considered COVID‐19‐vaccine related. Our study highlights an increase in ITP cases at our institution, probably related to COVID‐19 vaccinations. Further studies are needed to investigate this finding globally.
               
Click one of the above tabs to view related content.